UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Uncover the various options for using your credit card points effectively. Make the most of your rewards!
28,235 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A sky‑high dividend can be tempting, but it often signals trouble. This guide explains how to tell whether this ultim...
Perplexity's CEO argues that embracing the risk of idea theft keeps a fast-moving AI startup on its toes. The comment...
A fresh look at ProShares UltraPro QQQ reveals that while the fund lists a 0.82% annual expense, the real erosion com...
A fabless-focused ETF has surged roughly 58% this year as AI-driven design gains power, all while avoiding the world'...
A new growth-focused ETF with a 0.03% expense ratio has posted strong five-year outperformance versus the S&P 500, le...
As volatility persists in 2026, a small-cap dividend ETF is drawing renewed interest from retirees seeking steady inc...
IonQ delivers a standout Q1 and a fresh price-target outlook that signals potential triple-digit gains over the next ...
A prominent wealth manager warns that baby boomers with heavy equity in 401(K)s may face a tougher retirement path if...
Robinhood has evolved from a simple trading app to a platform with broader fintech ambitions. This article explores p...
The 2026 HousingWire Homebuilder Rankings broaden the field, adding new metrics that measure profitability and local ...
L’Oréal’s innovation chief says speed isn’t enough in AI-driven markets; enduring success comes from history, structu...